Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Cancer Science|April 2, 2008
Influence of ABCB1 and ABCG2 polymorphisms on doxorubicin disposition in Asian breast cancer patientsSuman Lal, Zee Wan Wong, Edwin Sandanaraj, et al.
Cancer Science|November 20, 2008
CBR1 and CBR3 pharmacogenetics and their influence on doxorubicin disposition in Asian breast cancer patientsSuman Lal, Edwin Sandanaraj, Zee Wan Wong, et al.
Drug Metabolism and Pharmacokinetics|September 12, 2009
VKORC1 diplotype-derived dosing model to explain variability in warfarin dose requirements in Asian patientsEdwin Sandanaraj, Suman Lal, Yin Bun Cheung, et al.
European Journal of Clinical Pharmacology|April 7, 2007
Pharmacogenetics of SLCO1B1: haplotypes, htSNPs and hepatic expression in three distinct Asian populationsSrinivasa Rao Jada, Shu Xiaochen, Liu Yan Yan, et al.
British Journal of Clinical Pharmacology|April 2, 2005
Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancerQingyu Zhou, Alex Sparreboom, Eng-Huat Tan, et al.
Cancer Science|July 14, 2007
Role of UGT1A1*6, UGT1A1*28 and ABCG2 c.421C>A polymorphisms in irinotecan-induced neutropenia in Asian cancer patientsSrinivasa Rao Jada, Robert Lim, Chiung Ing Wong, et al.
British Journal of Clinical Pharmacology|November 13, 2007
Influence of APOE genotypes and VKORC1 haplotypes on warfarin dose requirements in Asian patientsSuman Lal, Edwin Sandanaraj, Srinivasa Rao Jada, et al.
British Journal of Clinical Pharmacology|October 15, 2011
Influence of SLCO1B3 haplotype-tag SNPs on docetaxel disposition in Chinese nasopharyngeal cancer patientsSin Chi Chew, Edwin Sandanaraj, Onkar Singh, et al.
Pageof 9